Information Provided By: 
Fly News Breaks for August 13, 2015
CYNO, ZLTQ
Aug 13, 2015 | 05:33 EDT
After spending time with management, Piper Jaffray analyst Matt O'Brien says ZELTIQ Aesthetics is "quickly becoming" one of his firm's favorite names. The competitive launch from Cynosure (CYNO) is worth monitoring but unlikely to impact ZELTIQ's growth trajectory, O'Brien tells investors in a research note. The analyst is confident in the company's ability to post 20% annual top-line growth in the coming years. He keeps an Overweight rating on ZELTIQ with a $40 price target.
News For ZLTQ;CYNO From the Last 2 Days
There are no results for your query ZLTQ;CYNO
